Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,214.1
19.4 (0.61%)

 

  • STI Straits Times Index
    3,214.1
    19.4 (0.61%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,571.2
    3.8 (0.24%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    27,687.8
    693.6 (2.57%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,967.7
    52.0 (1.78%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    24,023.1
    598.3 (2.55%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,197.3
    57.9 (0.94%)
    Index delayed 10 minutes
  • KOR KOSPI
    2,170.2
    32.9 (1.54%)
    Index delayed 20 minutes
  • XAO XAO
    6,844.6
    33.8 (0.50%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 969.2M
  • Value: 1,355.0M
  • Rise: 174
  • Fall: 117
  • Unch: 535

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Rex Intl0.186+0.007
Golden Agri-Res0.220-
YZJ Shipbldg SGD1.130+0.040
Artivision Tech0.003-0.001
Ascendas Reit2.910-0.080
CapitaMall Trust2.420-0.040
Genting Sing0.930-0.005
ThaiBev0.920+0.010
Mapletree Com Tr2.260-0.020
SingTel3.390-

World Indices

World Indices
Name Last Change
Nasdaq 8,734.9 +17.6
HSI 27,687.8 +693.6
HSCEI 10,838.1 +223.3
Jakarta 6,197.3 +57.9
Nikkei 225 24,023.1 +598.3
SSE Comp 2,967.7 +52.0
Shanghai A 3,109.7 +54.5
Shanghai B 245.9 +3.2
PSE Comp 0.0
KOSPI 2,170.2 +32.9

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

SINOMAB BIO-B SINOMAB BIO-B
Quotes 15 Minutes Delayed. Updated at 13 Dec 2019 16:08
Last (HKD): 3.980 Change: -0.040 High: 4.040 Remarks: -
Change (%): -1.00 Low: 3.910
Open 4.030 Yesterday's Close 4.020
Buy Price 3.980 Sell Price 3.980
Buy Volume ('000) 0.3 Sell Volume ('000) 3.3
Cumulative Volume ('000) 782.7 Cumulative Value 3,110,979
Click to show Stock Prices chart

Key Statistics

EPS (HKD) a - Trailing EPS (HKD) e - NAV (HKD) b -
PE a - Trailing PE f - Price / NAV b -
Dividend (HKD) d - Cash In Hand (HKD) g - Issued & Paid-up Shares c 1,006,240,000
Dividend Yield (%) d - Price / Cash In Hand g - Treasury Shares h -
Beta - 75 Daysi -41.984 R-Squared - 75 Days(%)i 100.00 Market Cap (M) 4,004.835
Beta - 500 Daysi -41.043 R-Squared - 500 Days (%)i 100.00 Enterprise Value (M) 4,004.835
Piotroski F Score - Exchange Code 3681 Par Value ( HKD ) n.a.
52 Weeks Volatility (%) n.a. 6-Month VWAP n.a. Free Float (%) 22.1
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 13 Nov 2019.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 06 Nov 2019.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference SINOMAB BIO-B HKEx 4,004.835 - - - -
Industry Biotechnology HKEx 47,822.332 14.073 15.031 6.0083 2.596
Local Peer AMGEN-T HKEx 594,184.000 9.032 9.399 6.9364 4.385
Local Peer SINO BIOPHARM HKEx 129,562.909 12.092 12.549 3.8585 0.710
Local Peer WUXI BIO HKEx 121,568.327 162.763 127.243 12.5139 -
Local Peer BEIGENE HKEx 85,666.018 - - 8.5473 -
Local Peer GENSCRIPT BIO HKEx 34,877.863 209.745 - 9.8354 -
Local Peer 3SBIO HKEx 27,025.281 17.865 21.745 2.6637 -
Local Peer HAOHAI BIOTEC HKEx 13,164.762 26.812 29.715 3.0996 0.790
Local Peer FRONTAGE HKEx 8,853.692 100.501 100.494 4.5823 -
Local Peer CKLIFE SCIENCES HKEx 7,592.745 28.874 28.834 1.8186 1.266
Local Peer VIVA BIOTECH HKEx 6,812.041 63.513 63.514 3.5366 -
Local Peer ASCENTAGE-B HKEx 6,131.068 - - -3.3200 -
Local Peer ASCLETIS-B HKEx 3,675.863 - - 0.9537 -
Other Local Peers ESSEX BIO-TECH (HKEx), LEE'S PHARM (HKEx), BBI LIFE SCI (HKEx), UNI-BIO GROUP (HKEx), CT ENTERPRISE (HKEx), BIOSINO BIO-TEC (HKEx), REGENT PACIFIC (HKEx), EXTRAWELL PHAR (HKEx), HAO WEN HLDGS (HKEx)
Global Peer AMGEN INC NASDAQ 140,667.120 16.758 17.437 12.8734 2.363
Global Peer CSL ASX 126,230.603 47.050 47.050 16.8686 0.954
Global Peer GILEAD SCIENCES INC NASDAQ 83,208.916 15.254 30.898 4.0385 3.513
Global Peer VERTEX PHARMACEUTICAL NASDAQ 56,310.707 26.861 26.267 10.7189 -
Global Peer BIOGEN INC NASDAQ 53,560.599 12.089 9.927 3.8269 -
Global Peer ILLUMINA INC NASDAQ 47,733.840 57.789 49.058 10.7533 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 41,329.399 16.908 19.275 3.9345 -
Global Peer AGILENT TECHNOLOGIES INC NYSE 25,905.566 81.979 24.188 5.4561 0.732
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 24,434.952 314.883 16.619 2.3569 -
Global Peer INCYTE CORPORATION NASDAQ 19,710.979 180.021 48.673 8.1365 -
Other Global Peers SEATTLE GENETICS INC (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), EXACT SCIENCES CORP (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), MODERNA INC (NASDAQ), 10X GENOMICS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), EXELIXIS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), REPLIGEN CORP (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), Lonza (SGX), IMMUNOMEDICS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), FIBROGEN INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), UNIQURE N.V. (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), HALOZYME THERAPEUTICS INC (NASDAQ), NATERA INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), SYNTHORX INC (NASDAQ), XENCOR INC (NASDAQ), INSMED INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), ARVINAS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), EPIZYME INC (NASDAQ), REGENXBIO INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), ESPERION THERAPEUTICS INC (NASDAQ), VERACYTE INC (NASDAQ), NEXTCURE INC (NASDAQ), ALECTOR INC (NASDAQ), VIELA BIO INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), OPKO HEALTH INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), INTREXON CORP (NASDAQ), CORTEXYME INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), XBIOTECH INC (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), POLYNOVO LIMITED (ASX), AVITA MEDICAL LTD (ASX), STOKE THERAPEUTICS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), KADMON HLDGS INC (NYSE), AKEBIA THERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), OMEROS CORP (NASDAQ), DERMIRA INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), MESOBLAST LTD (ASX), SORRENTO THERAPEUTICS INC (NASDAQ), AVROBIO INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), RETROPHIN INC (NASDAQ), ARDELYX INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), CYTOKINETICS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), IMMUNOGEN INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), AGENUS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), MERUS B V (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), MORPHIC HOLDING INC (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), AVID BIOSERVICES INC (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), PDL BIOPHARMA INC (NASDAQ), BELLUS HEALTH INC (NASDAQ), RECRO PHARMA INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), COMPUGEN (NASDAQ), MEDICINOVA INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), STARPHARMA HOLDINGS LIMITED (ASX), CYTOMX THERAPEUTICS INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), PERSONALIS INC (NASDAQ), GERON CORP (NASDAQ), KAMADA (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), CUE BIOPHARMA INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), IVERIC BIO INC (NASDAQ), PFENEX INC (NYSE American), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), TELIX PHARMACEUTIC (ASX), APTOSE BIOSCIENCES INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), DPHARMA (Bursa), CHIASMA INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), NANTKWEST INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), NEXT SCIENCE LTD (ASX), XOMA CORP (NASDAQ), ATHERSYS INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), ARAVIVE INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), AFFIMED N V (NASDAQ), CABALETTA BIO INC (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), MERSANA THERAPEUTICS INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), VBI VACCINES INC CDA (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), IMV INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), NANOVIRICIDES INC (NYSE American), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), FENNEC PHARMACEUTICALS INC (NASDAQ), ENZO BIOCHEM INC (NYSE), CYMABAY THERAPEUTICS INC (NASDAQ), CHIMERIX INC (NASDAQ), RESAPP HEALTH LIMITED (ASX), SESEN BIO INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), PYC THERAPEUTICS LIMITED (ASX), HARVARD BIOSCIENCE INC (NASDAQ), NOVAVAX INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), LINEAGE CELL THERAPEUTICS INC (NYSE American), VERASTEM INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), ADURO BIOTECH INC (NASDAQ), 22ND CENTURY GROUP INC (NYSE American), LA JOLLA PHARMACEUTICAL CO (NASDAQ), IMUGENE LIMITED (ASX), VTV THERAPEUTICS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), INFLARX N V (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), SYNLOGIC INC (NASDAQ), EQUILLIUM INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), VACCINEX INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), CYNATA THERAPEUTICS LTD (ASX), OTONOMY INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), VERMILLION INC (NASDAQ), COHBAR INC (NASDAQ), CEL-SCI CORP (NYSE American), TREVENA INC (NASDAQ), ONCOSIL MEDICAL LIMITED (ASX), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), IMMUTEP LTD (ASX), MERRIMACK PHARMACEUTICALS INC (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), ORTHOCELL LIMITED (ASX), GENOCEA BIOSCIENCES INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), T2 BIOSYSTEMS INC (NASDAQ), SAVARA INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), CURIS INC (NASDAQ), INMUNE BIO INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), ORGENESIS INC (NASDAQ), RESTORBIO INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), PORT (SET), ALIMERA SCIENCES INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), ARMATA PHARMACEUTICALS INC (NYSE American), DIAMEDICA THERAPEUTICS INC (NASDAQ), EVOGENE LTD (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), ISORAY INC (NYSE American), OUTLOOK THERAPEUTICS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), INVEX THERAPEUTICS LTD NPV (ASX), NEON THERAPEUTICS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), BIONOMICS LTD (ASX), KAZIA THERAPEUTICS LIMITED (ASX), ZAFGEN INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), NOVITA HEALTHCARE LTD (ASX), FIBROCELL SCIENCE INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), BIOCARDIA INC (NASDAQ), ACTINOGEN MEDICAL LTD (ASX), APTEVO THERAPEUTICS INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), MEMPHASYS LTD (ASX), BIONANO GENOMICS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), CONTRAFECT CORP (NASDAQ), ORAGENICS INC (NYSE American), SOLIGENIX INC (NASDAQ), BIOTRON (ASX), VISTAGEN THERAPEUTICS INC (NASDAQ), PRESCIENT THERAPEUTICS LIMITED (ASX), IBIO INC (NYSE American), BIO-PATH HOLDINGS INC (NASDAQ), RHINOMED LIMITED (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), CELLECTAR BIOSCIENCES INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), PROTEOMICS INTL LABORATORIES LTD (ASX), UNUM THERAPEUTICS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), IMMURON LIMITED (ASX), CO DIAGNOSTICS INC (NASDAQ), ANTEOTECH LIMITED (ASX), ADVAXIS INC (NASDAQ), CELLMID LIMITED (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), AETERNA ZENTARIS INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), REGENEUS LTD (ASX), HEAT BIOLOGICS INC (NASDAQ), PATRYS LIMITED (ASX), ATYR PHARMA INC (NASDAQ), SENESTECH INC (NASDAQ), VAXART INC (NASDAQ), CONTANGO ASSET MANAGEMENT LIMITED (ASX), GENETIC TECHNOLOGIES (ASX), Suntar Eco-City^ (SGX), PRECIPIO INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED (ASX), HOLISTA COLLTECH LIMITED (ASX), SOPHIRIS BIO INC (NASDAQ), TOCAGEN INC (NASDAQ), OCUGEN INC (NASDAQ), ADALTA LTD (ASX), CONATUS PHARMACEUTICALS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), CCP TECHNOLOGIES LTD (ASX), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), BIOCEPT INC (NASDAQ), CYCLACEL PHARMA IN (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), TROVAGENE INC (NASDAQ), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), BENITEC BIOPHARMA LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), BENITEC BIOPHARMA LTD SPON ADS EA REPR 200 ORD SHS(POST SPLIT) (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), AUSTRALIAN PRIMARY HEMP LTD (ASX), MEGASUN (Bursa), PLUS THERAPEUTICS INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), MGRC (Bursa), XENETIC BIOSCIENCES INC (NASDAQ), SIENNA CANCER DIAGNOSTICS LTD (ASX), MEDIBIO LIMITED (ASX), ANATARA LIFESCIENCES LTD (ASX), TBG DIAGNOSTICS LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), OPGEN INC (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), BIOXYNE LIMITED (ASX), ACHIEVE LIFE SCIENCE INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), AVECHO BIOTECHNOLOGY LTD (ASX), DIFFUSION PHARMACEUTICALS INC (NASDAQ), AIM IMMUNOTECH INC (NYSE American), SENECA BIOPHARMA INC (NASDAQ), SPHERIX INC (NASDAQ), QT Vascular (SGX), AURIS MEDICAL HOLDING LTD (NASDAQ), NANOLLOSE LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), FACTOR THERAPEUTICS LIMITED (ASX), BPH ENERGY LIMITED (ASX), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.050
-1.24 %
10 Days --0.300
-7.01 %
20 Days --0.820
-17.08 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 3.810 - 7.300 Change From 1 Year Low +0.170 % Change From 1 Year Low (%) +4.46
Change From 1 Year High -3.320 % Change From 1 Year High (%) -45.48
2 Years Range 3.810 - 7.300 Change From 2 Years Low +0.170 % Change From 2 Years Low (%) +4.46
Change From 2 Years High -3.320 % Change From 2 Years High (%) -45.48
5 Years Range 3.810 - 7.300 Change From 5 Years Low +0.170 % Change From 5 Years Low (%) +4.46
Change From 5 Years High -3.320 % Change From 5 Years High (%) -45.48
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

SinoMab Bioscience Ltd. operates as a clinical stage biopharmaceutical company. It creates and develops therapeutic antibodies for the treatment of life-threatening and other debilitating diseases. The company was founded by Shui On Leung on April 27, 2001 and is headquartered in Hong Kong.

Historical Price Data

Date Open High Low Close Volume VWAP
13 Dec 2019 4.030 4.040 3.910 3.980 782,700 3.9747
12 Dec 2019 4.070 4.200 4.020 4.020 478,500 4.0877
11 Dec 2019 3.990 4.040 3.900 4.020 890,400 3.9464
10 Dec 2019 3.980 4.070 3.880 3.990 1,086,600 3.9954
09 Dec 2019 4.010 4.060 3.980 4.000 392,700 4.0107
06 Dec 2019 3.960 4.180 3.960 4.030 1,132,800 4.0754
05 Dec 2019 3.920 4.040 3.880 4.000 1,168,800 4.0030
04 Dec 2019 3.820 3.980 3.810 3.920 642,600 3.9226
03 Dec 2019 4.000 4.050 3.820 3.890 2,583,000 3.8921
02 Dec 2019 4.280 4.300 4.010 4.050 1,506,300 4.0982
29 Nov 2019 4.400 4.400 4.280 4.280 1,481,700 4.3066
28 Nov 2019 4.520 4.700 4.380 4.400 1,923,300 4.4707
27 Nov 2019 4.440 4.580 4.380 4.520 1,430,100 4.4526
26 Nov 2019 4.580 4.580 4.370 4.440 1,412,400 4.4537
25 Nov 2019 4.610 4.720 4.520 4.580 1,322,700 4.5800
22 Nov 2019 4.740 4.800 4.580 4.610 2,496,000 4.6542
21 Nov 2019 4.870 4.920 4.700 4.700 1,564,200 4.7817
20 Nov 2019 4.990 5.220 4.800 4.920 5,388,900 5.0006
19 Nov 2019 4.630 5.030 4.450 5.010 7,287,000 4.8305
18 Nov 2019 4.890 4.980 4.560 4.600 4,728,000 4.7224
15 Nov 2019 4.490 4.850 4.490 4.800 15,012,600 4.7257
14 Nov 2019 4.610 4.980 4.250 4.420 17,529,000 4.5809
Summary
Current 2 Weeks
(02 Dec 2019 to 13 Dec 2019)
4.280 4.300 3.810 3.980 10,664,400 -
Previous 2 Weeks
(18 Nov 2019 to 29 Nov 2019)
4.890 4.980 3.810 4.280 29,034,300 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.